{"url_path":"/sec/rdhl/10-k/2026/item-16j","section_key":"item-16j","section_title":"Item 16J ****INSIDER TRADING POLICIES**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1553846/0001104659-26-049055-index.html","accession_number":"0001104659-26-049055","cik":"0001553846","ticker":"RDHL","issuer_name":"RedHill Biopharma Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1553846/0001104659-26-049055-index.html","primary_entity_key":"0001553846","primary_entity_name":"RedHill Biopharma Ltd."},"word_count":72,"has_tables":true,"body_markdown":"**ITEM 16J.        ****INSIDER TRADING POLICIES**\n\n​\n\nThe Company’s Board of Directors adopted an Insider Trading Policy in May 2022, of which a copy is included as Exhibit 11.1 to this Annual Report, that governs the trading in the Company’s securities by its directors, officers, employees and certain other covered persons, and which is reasonably designed to promote compliance with applicable insider trading laws, rules and regulations and applicable Nasdaq listing standards.\n\n​"}